Patient care navigation and health copilot AI
VisitRecall
VisitRecall is winding down. Recording ends September 30, 2026. Users can download or delete records through December 31, 2026, after which the service says remaining data will be permanently deleted. Its published restriction on using outputs against providers remains relevant to the exported record.
Recording ends September 30, 2026. Export access ends December 31, 2026. Historical scores are retained in the report.
Summary judgment · Unscored in current comparisons
Recording ends September 30, 2026. Export access ends December 31, 2026. Historical axis: 78/100.
Mixed
VisitRecall is winding down. Recording ends September 30, 2026. Users can download or delete records through December 31, 2026, after which the service says remaining data will be permanently deleted. Its published restriction on using outputs against providers remains relevant to the exported record.
Patient agency
How this tool changes agency
Readable records and raw transcript data can preserve the basis for later checking and advocacy. Missing audio and untested export completeness limit reconstruction. Future visit prompts and booking should no longer lead a description of a closing product.
Export completeness, family permissions, actual deletion, subscription handling and the continuing legal effect of the restriction were not tested or adjudicated.
Patient agency assessment
Who sets and changes the goal?
The patient's immediate task is preserving a usable independent record before the service ends. Export may extend authority beyond the vendor, but the surviving published restriction on evidence use constrains what users are told they may do with it. Managed-profile authority and family-shared records are explicitly different.
What can the patient understand, question, or do?
Readable records and raw transcript data can preserve the basis for later checking and advocacy. Missing audio and untested export completeness limit reconstruction. Future visit prompts and booking should no longer lead a description of a closing product.
Can the patient evaluate the conditions of use?
The dated closure notice makes continuity and exit conditions concrete. The general claim that everything is yours to take does not expressly repeal the legal-use clause. Whether that clause is enforceable is not determined here.
Text findings
Conditions of use
Published controls and their limits
The dated closure notice makes continuity and exit conditions concrete. The general claim that everything is yours to take does not expressly repeal the legal-use clause. Whether that clause is enforceable is not determined here.
What remains unknown?
Not tested or not established
Export completeness, family permissions, actual deletion, subscription handling and the continuing legal effect of the restriction were not tested or adjudicated.
Who evaluated this?
AI-assisted public-source draft
Vendor statements describe published conditions, not independently verified behavior. No clinical, security, accessibility, or legal validation is claimed. Earlier evidence remains dated in the report and history.
Sources checked
- https://visitrecall.com/
- https://visitrecall.com/manage-my-data/
- https://visitrecall.com/terms
- https://visitrecall.com/privacy
Source-specific findings and retrieval limitations are recorded in the full report.
Review provenance
Criteria
CAIHL-derived HugoScore framework and September 7 qualitative review priorities. Draft v1.2 numerical anchors remain unadopted.
Reviewer
AI-assisted public-source reassessment prepared in OpenAI Codex.
AI / model
OpenAI Codex / GPT-6
Human review
Hugo Campos authorized publication of these AI-assisted draft reassessments on September 8, 2026. This does not claim comprehensive human verification of every finding.
Review date
2026-09-08
Limitations
Export completeness, family permissions, actual deletion, subscription handling and the continuing legal effect of the restriction were not tested or adjudicated. No live product use, patient-data upload, account creation, code audit, clinical evaluation, or independent implementation validation.
Review method
Focused public-source reassessment using CAIHL: patient authority, critical capacity, and informed control. Existing evidence plus one focused primary-source pass and at most one targeted follow-up. No live product testing. Numerical scores remain provisional editorial placements, not a new calculation.
Winding down · High for the retrieved dated closure announcement and published clause, limited for export implementation (AI-assisted draft)